Home
  • About Us
    • Inside Absci
    • Team
    • Our Values
  • Our Technology
  • Our Science
    • Publications
    • Case Studies
    • All
  • Pipeline
  • Partner With Us
  • Investors
  • Careers
    • Current Openings
  • Contact Us

Ideas to Impact

Mar 23, 2022

Absci is unlocking the potential of next-generation biologics by merging cutting edge AI models of protein function with experimental biology to explore a vast therapeutic sequence space inaccessible to traditional methods. For more information visit www.absci.com and follow us on social media: Twitter: @abscibio, LinkedIn: @absci.

Related

The Pre-clinical Science Behind ABS-201 for Endometriosis

Prolactin Receptor Blockade With ABS-201 Relieves Pain and Inflammation in a Homologous Transplant Mouse Model of Endometriosis

ABS-201 Case Study

Share this post


Related Resources


The Pre-clinical Science Behind ABS-201 for Endometriosis

Read More

Prolactin Receptor Blockade With ABS-201 Relieves Pain and Inflammation in a Homologous Transplant Mouse Model of Endometriosis

Read More

ABS-201 Case Study

Read More
Site
  • About Absci
  • Our Technology
  • Our Science
  • Pipeline
  • Partner With Us
  • Investors
  • Careers
Connect
  • Contact Us
  • LinkedIn
  • X/Twitter
  • YouTube

Unlocking differentiated biology with generative AI

  • Privacy
  • Terms

© Copyright 2026 Absci Corp.

  • Twitter
  • linkedin
  • YouTube
You’re leaving the Absci website. This link is provided for your convenience, but the content is the sole responsibility of its owner. Do you want to continue?
Return to the Absci website at any time by using the “Back” button on your web browser.
YES
NO